nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—prostate cancer	0.482	0.82	CbGaD
Lucanthone—TOP2A—prostate cancer	0.106	0.18	CbGaD
Lucanthone—TOP2A—Mitoxantrone—prostate cancer	0.0963	0.348	CbGbCtD
Lucanthone—TOP2A—Epirubicin—prostate cancer	0.0779	0.282	CbGbCtD
Lucanthone—TOP2A—Etoposide—prostate cancer	0.0607	0.22	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—prostate cancer	0.0414	0.15	CbGbCtD
Lucanthone—APEX1—prostate gland—prostate cancer	0.00448	0.111	CbGeAlD
Lucanthone—APEX1—seminal vesicle—prostate cancer	0.00379	0.0941	CbGeAlD
Lucanthone—APEX1—epithelium—prostate cancer	0.00329	0.0817	CbGeAlD
Lucanthone—TOP1—prostate gland—prostate cancer	0.00314	0.0778	CbGeAlD
Lucanthone—APEX1—renal system—prostate cancer	0.00306	0.0758	CbGeAlD
Lucanthone—APEX1—urethra—prostate cancer	0.003	0.0744	CbGeAlD
Lucanthone—TOP1—seminal vesicle—prostate cancer	0.00265	0.0658	CbGeAlD
Lucanthone—APEX1—bone marrow—prostate cancer	0.00231	0.0573	CbGeAlD
Lucanthone—TOP2A—prostate gland—prostate cancer	0.00223	0.0554	CbGeAlD
Lucanthone—TOP1—urethra—prostate cancer	0.0021	0.0521	CbGeAlD
Lucanthone—APEX1—testis—prostate cancer	0.00197	0.049	CbGeAlD
Lucanthone—TOP1—bone marrow—prostate cancer	0.00162	0.0401	CbGeAlD
Lucanthone—APEX1—lymph node—prostate cancer	0.00143	0.0355	CbGeAlD
Lucanthone—TOP1—testis—prostate cancer	0.00138	0.0343	CbGeAlD
Lucanthone—TOP2A—bone marrow—prostate cancer	0.00115	0.0285	CbGeAlD
Lucanthone—TOP1—lymph node—prostate cancer	0.001	0.0248	CbGeAlD
Lucanthone—TOP2A—testis—prostate cancer	0.000983	0.0244	CbGeAlD
Lucanthone—TOP2A—lymph node—prostate cancer	0.000713	0.0177	CbGeAlD
Lucanthone—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000602	0.189	CbGdCrCtD
Lucanthone—Procainamide—DNMT1—prostate cancer	0.00051	0.184	CrCbGaD
Lucanthone—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000416	0.13	CbGdCrCtD
Lucanthone—APEX1—Doxorubicin—Epirubicin—prostate cancer	0.000358	0.112	CbGdCrCtD
Lucanthone—Procainamide—SLC22A3—prostate cancer	0.000333	0.12	CrCbGaD
Lucanthone—APEX1—Epirubicin—Doxorubicin—prostate cancer	0.000331	0.104	CbGdCrCtD
Lucanthone—Procainamide—ACHE—prostate cancer	0.000302	0.109	CrCbGaD
Lucanthone—Amiodarone—CYP3A5—prostate cancer	0.000291	0.105	CrCbGaD
Lucanthone—Amiodarone—CYP2A6—prostate cancer	0.000282	0.102	CrCbGaD
Lucanthone—APEX1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000244	0.0765	CbGdCrCtD
Lucanthone—Procainamide—SLC22A1—prostate cancer	0.000239	0.0864	CrCbGaD
Lucanthone—Amiodarone—CYP2C19—prostate cancer	0.000198	0.0716	CrCbGaD
Lucanthone—Amiodarone—CYP1A1—prostate cancer	0.000197	0.0714	CrCbGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	0.00019	0.00212	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—prostate cancer	0.000189	0.0021	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	0.000184	0.00205	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—ID3—prostate cancer	0.000183	0.00203	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—APC—prostate cancer	0.000181	0.00202	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	0.00018	0.00201	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MAP2K1—prostate cancer	0.000179	0.002	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—prostate cancer	0.000176	0.00196	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—TERT—prostate cancer	0.000175	0.00195	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	0.000175	0.00195	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SIRT1—prostate cancer	0.000173	0.00193	CbGpPWpGaD
Lucanthone—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.000173	0.0541	CbGdCrCtD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—prostate cancer	0.00017	0.0019	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	0.000168	0.00187	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TYMS—prostate cancer	0.000168	0.00187	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ERCC2—prostate cancer	0.000167	0.00186	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—JAK2—prostate cancer	0.000164	0.00182	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	0.000161	0.00179	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	0.000151	0.00168	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—prostate cancer	0.000146	0.00163	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDKN1B—prostate cancer	0.000146	0.00162	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PPARA—prostate cancer	0.000144	0.0016	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LEP—prostate cancer	0.000141	0.00157	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—ATM—prostate cancer	0.000141	0.00157	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TLR4—prostate cancer	0.000138	0.00154	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	0.000137	0.00152	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—LEP—prostate cancer	0.000136	0.00152	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	0.000136	0.00151	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	0.000136	0.00151	CbGpPWpGaD
Lucanthone—Flurazepam—CYP2A6—prostate cancer	0.000133	0.0482	CrCbGaD
Lucanthone—APEX1—Spinal Cord Injury—ICAM1—prostate cancer	0.000133	0.00148	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	0.000132	0.00147	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—ATM—prostate cancer	0.000131	0.00146	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—AKT1—prostate cancer	0.000129	0.00143	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	0.000128	0.00143	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	0.000127	0.00141	CbGpPWpGaD
Lucanthone—Amiodarone—CYP3A4—prostate cancer	0.000126	0.0456	CrCbGaD
Lucanthone—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000126	0.0395	CbGdCrCtD
Lucanthone—APEX1—TSH signaling pathway—SRC—prostate cancer	0.000124	0.00139	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—STAT3—prostate cancer	0.00012	0.00134	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	0.000119	0.00132	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GSK3B—prostate cancer	0.000118	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—GSK3B—prostate cancer	0.000118	0.00131	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	0.000117	0.00131	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—CTNNB1—prostate cancer	0.000117	0.0013	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PSMC3IP—prostate cancer	0.000114	0.00127	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	0.000113	0.00126	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HNF1B—prostate cancer	0.000113	0.00126	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—prostate cancer	0.000112	0.00124	CbGpPWpGaD
Lucanthone—TOP2A—Podofilox—Etoposide—prostate cancer	0.000111	0.0348	CbGdCrCtD
Lucanthone—TOP2A—Teniposide—Etoposide—prostate cancer	0.000111	0.0348	CbGdCrCtD
Lucanthone—TOP2A—Levorphanol—Estrone—prostate cancer	0.00011	0.0344	CbGdCrCtD
Lucanthone—APEX1—Synthesis of DNA—CDKN1B—prostate cancer	0.000108	0.0012	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	0.000108	0.0012	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—SERPINE1—prostate cancer	0.000107	0.00119	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	0.000107	0.00119	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HIST1H2BG—prostate cancer	0.000106	0.00117	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	0.000103	0.00114	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	0.000103	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—prostate cancer	0.000102	0.00114	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HIST1H4H—prostate cancer	0.000102	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—USO1—prostate cancer	0.000102	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PCNT—prostate cancer	0.000102	0.00113	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—prostate cancer	0.000101	0.00113	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	0.000101	0.00112	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PRKDC—prostate cancer	0.000101	0.00112	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—prostate cancer	9.97e-05	0.00111	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	9.96e-05	0.00111	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	9.74e-05	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	9.74e-05	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—prostate cancer	9.69e-05	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—REC8—prostate cancer	9.68e-05	0.00108	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—prostate cancer	9.67e-05	0.00108	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—AHR—prostate cancer	9.59e-05	0.00107	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAD1L1—prostate cancer	9.58e-05	0.00107	CbGpPWpGaD
Lucanthone—Flurazepam—CYP2E1—prostate cancer	9.48e-05	0.0343	CrCbGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—prostate cancer	9.47e-05	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—prostate cancer	9.44e-05	0.00105	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HIST1H2BG—prostate cancer	9.44e-05	0.00105	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL8—prostate cancer	9.38e-05	0.00104	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—prostate cancer	9.35e-05	0.00104	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—prostate cancer	9.24e-05	0.00103	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	9.22e-05	0.00103	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—prostate cancer	9.16e-05	0.00102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HIST1H4H—prostate cancer	9.11e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—USO1—prostate cancer	9.1e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PCNT—prostate cancer	9.1e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	9.04e-05	0.00101	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—prostate cancer	8.98e-05	0.000999	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—prostate cancer	8.96e-05	0.000998	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—prostate cancer	8.86e-05	0.000986	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	8.8e-05	0.000979	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—prostate cancer	8.74e-05	0.000973	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	8.73e-05	0.000972	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	8.71e-05	0.00097	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	8.68e-05	0.000966	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAD1L1—prostate cancer	8.57e-05	0.000954	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	8.51e-05	0.000948	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	8.49e-05	0.000945	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—prostate cancer	8.48e-05	0.000944	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	8.47e-05	0.000943	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—prostate cancer	8.45e-05	0.000941	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND2—prostate cancer	8.38e-05	0.000933	CbGpPWpGaD
Lucanthone—TOP2A—Levorphanol—Estradiol—prostate cancer	8.32e-05	0.0261	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—TOP2A—prostate cancer	8.31e-05	0.000925	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	8.28e-05	0.000922	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—prostate cancer	8.18e-05	0.00091	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—prostate cancer	8.15e-05	0.000908	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	8.1e-05	0.000902	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—AURKA—prostate cancer	7.93e-05	0.000882	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	7.9e-05	0.000879	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—NBN—prostate cancer	7.88e-05	0.000878	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	7.88e-05	0.000877	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH1—prostate cancer	7.84e-05	0.000873	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	7.78e-05	0.000867	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—prostate cancer	7.77e-05	0.000866	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—prostate cancer	7.75e-05	0.000863	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—prostate cancer	7.74e-05	0.000861	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	7.67e-05	0.000854	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	7.6e-05	0.0238	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	7.54e-05	0.000839	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TOP2A—prostate cancer	7.43e-05	0.000827	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	7.41e-05	0.000825	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NCOA2—prostate cancer	7.34e-05	0.000817	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EZH2—prostate cancer	7.24e-05	0.000806	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—TYMS—prostate cancer	7.21e-05	0.000802	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—AURKA—prostate cancer	7.09e-05	0.000789	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	7.06e-05	0.000786	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	7.04e-05	0.000784	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—prostate cancer	7.01e-05	0.00078	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TGFB1—prostate cancer	6.99e-05	0.000778	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	6.99e-05	0.000778	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	6.9e-05	0.000768	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—prostate cancer	6.85e-05	0.000763	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—prostate cancer	6.78e-05	0.000755	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	6.77e-05	0.000754	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	6.71e-05	0.000746	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TH—prostate cancer	6.66e-05	0.000742	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND2—prostate cancer	6.64e-05	0.00074	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	6.54e-05	0.000728	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.52e-05	0.000726	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	6.35e-05	0.000706	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CHEK2—prostate cancer	6.34e-05	0.000706	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EGR1—prostate cancer	6.28e-05	0.000699	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NGFR—prostate cancer	6.24e-05	0.000694	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	6.17e-05	0.000687	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	6.12e-05	0.000682	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.99e-05	0.000667	CbGpPWpGaD
Lucanthone—Flurazepam—CYP3A4—prostate cancer	5.97e-05	0.0216	CrCbGaD
Lucanthone—APEX1—Cell Cycle—BRCA1—prostate cancer	5.94e-05	0.000661	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND2—prostate cancer	5.94e-05	0.000661	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—prostate cancer	5.92e-05	0.000659	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	5.8e-05	0.000645	CbGpPWpGaD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—prostate cancer	5.78e-05	0.0181	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—prostate cancer	5.78e-05	0.0181	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—prostate cancer	5.78e-05	0.0181	CbGdCrCtD
Lucanthone—APEX1—Spinal Cord Injury—TP53—prostate cancer	5.75e-05	0.000641	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	5.74e-05	0.000639	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TYMS—prostate cancer	5.71e-05	0.000636	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	5.63e-05	0.000627	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—prostate cancer	5.56e-05	0.000619	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	5.46e-05	0.000608	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—prostate cancer	5.4e-05	0.000602	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SIRT1—prostate cancer	5.4e-05	0.000601	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—prostate cancer	5.37e-05	0.000598	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—prostate cancer	5.35e-05	0.0168	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	5.35e-05	0.0168	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—prostate cancer	5.35e-05	0.0168	CbGdCrCtD
Lucanthone—APEX1—Spinal Cord Injury—IL6—prostate cancer	5.27e-05	0.000586	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	5.26e-05	0.000585	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TYMS—prostate cancer	5.24e-05	0.000583	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—prostate cancer	5.16e-05	0.000574	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TYMS—prostate cancer	5.11e-05	0.000569	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—prostate cancer	5.09e-05	0.000567	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	5.02e-05	0.000558	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—prostate cancer	4.99e-05	0.000555	CbGpPWpGaD
Lucanthone—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	4.95e-05	0.0155	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.89e-05	0.000545	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HIST1H2BG—prostate cancer	4.88e-05	0.000543	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HIST1H4H—prostate cancer	4.71e-05	0.000525	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PPARA—prostate cancer	4.49e-05	0.0005	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—prostate cancer	4.45e-05	0.000496	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAD1L1—prostate cancer	4.43e-05	0.000493	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HIST1H2BG—prostate cancer	4.36e-05	0.000486	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	4.27e-05	0.000476	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—LEP—prostate cancer	4.26e-05	0.000474	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	4.24e-05	0.000472	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HIST1H4H—prostate cancer	4.21e-05	0.000469	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	4.14e-05	0.000461	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	4.14e-05	0.00046	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	4.01e-05	0.000446	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—ATM—prostate cancer	4e-05	0.000445	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAD1L1—prostate cancer	3.96e-05	0.000441	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	3.96e-05	0.000441	CbGpPWpGaD
Lucanthone—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	3.94e-05	0.0124	CbGdCrCtD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	3.8e-05	0.000423	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	3.71e-05	0.000414	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GSK3B—prostate cancer	3.69e-05	0.000411	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	3.67e-05	0.000408	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—AURKA—prostate cancer	3.67e-05	0.000408	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—NBN—prostate cancer	3.65e-05	0.000406	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—prostate cancer	3.63e-05	0.000404	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH1—prostate cancer	3.62e-05	0.000404	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	3.55e-05	0.000395	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	3.51e-05	0.000391	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	3.4e-05	0.000378	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	3.37e-05	0.000375	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—SERPINE1—prostate cancer	3.34e-05	0.000372	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—AURKA—prostate cancer	3.28e-05	0.000365	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	3.2e-05	0.000356	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—APEX1—prostate cancer	3.18e-05	0.000354	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	3.16e-05	0.000351	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	3.11e-05	0.000346	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND2—prostate cancer	3.07e-05	0.000342	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	3.04e-05	0.000339	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—prostate cancer	3.02e-05	0.000336	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—prostate cancer	2.95e-05	0.000329	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CHEK2—prostate cancer	2.93e-05	0.000326	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—prostate cancer	2.91e-05	0.000324	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	2.88e-05	0.000321	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—prostate cancer	2.88e-05	0.00032	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—APEX1—prostate cancer	2.85e-05	0.000317	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	2.82e-05	0.000314	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—prostate cancer	2.78e-05	0.00031	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	2.75e-05	0.000306	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA1—prostate cancer	2.75e-05	0.000306	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND2—prostate cancer	2.75e-05	0.000306	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	2.72e-05	0.000303	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1B—prostate cancer	2.7e-05	0.0003	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Prednisone—prostate cancer	2.67e-05	0.00837	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	2.66e-05	0.000296	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	2.65e-05	0.000295	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—prostate cancer	2.65e-05	0.000295	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TYMS—prostate cancer	2.64e-05	0.000294	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—prostate cancer	2.57e-05	0.000286	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—prostate cancer	2.55e-05	0.000284	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	2.53e-05	0.000282	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—prostate cancer	2.49e-05	0.000277	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—prostate cancer	2.48e-05	0.000277	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.46e-05	0.000274	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—prostate cancer	2.43e-05	0.00027	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.4e-05	0.000267	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—prostate cancer	2.37e-05	0.000264	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TYMS—prostate cancer	2.36e-05	0.000263	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—prostate cancer	2.31e-05	0.000257	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.2e-05	0.000245	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.2e-05	0.000245	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.16e-05	0.00024	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—prostate cancer	2.06e-05	0.00023	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—prostate cancer	2.06e-05	0.000229	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.04e-05	0.000227	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.87e-05	0.000208	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ATM—prostate cancer	1.85e-05	0.000206	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.81e-05	0.000202	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—prostate cancer	1.74e-05	0.000193	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—prostate cancer	1.69e-05	0.000189	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—prostate cancer	1.59e-05	0.000177	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.53e-05	0.00017	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.39e-05	0.000155	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—prostate cancer	1.37e-05	0.000152	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—prostate cancer	1.33e-05	0.000148	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.29e-05	0.000143	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—prostate cancer	1.25e-05	0.000139	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	1.22e-05	0.000136	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—prostate cancer	1.19e-05	0.000132	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—prostate cancer	1.15e-05	0.000128	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—prostate cancer	1.1e-05	0.000122	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	1.07e-05	0.000119	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—prostate cancer	9.54e-06	0.000106	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—prostate cancer	7.84e-06	8.72e-05	CbGpPWpGaD
